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Abstract
Propensity score methods are widely adopted in observational studies to adjust for
observed baseline confounding when either testing the null hypothesis that treatment
(or exposure) has no effect on an outcome or estimating the causal effect. However,
adjusting for all observed baseline covariates, when only a subset are confounders of
the treatment-outcome relation, is known to yield potentially inefficient and unsta-
ble estimators of the treatment effect. Similarly, randomization-based procedures that
condition on all observed covariates can be underpowered. For these stated reasons,
confounder (or covariate) selection is commonly used to determine a subset of the
available covariates that is sufficient for confounding adjustment. In this article, we
propose a confounder selection strategy that focuses on stable estimation of the treat-
ment effect. In particular, when the propensity score model already includes covariates
that are sufficient to adjust for confounding, then the addition of covariates that are
associated with either treatment or outcome alone, but not both, should not system-
atically change the effect estimator. The proposal, therefore, entails first prioritizing
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covariates for inclusion in the propensity score model, then using a change-in-estimate
approach to select the smallest adjustment set that yields a stable effect estimate. The
ability of the proposal to correctly select confounders, and to ensure valid inference of
the treatment effect following data-driven covariate selection, is assessed empirically
and compared with existing methods using simulation studies. We demonstrate the
procedure using three different publicly available datasets commonly used for causal
inference.
Keywords: Covariate selection, Full matching, Observational studies, Randomization infer-
ence, Sensitivity analysis
1 Introduction
When testing the null hypothesis that an exposure or a treatment has no causal effect on an
outcome in an observational study, observed baseline confounders must be adjusted or con-
trolled for to avoid bias. Randomization(-based) or conditional inference procedures achieve
this by comparing treated and untreated individuals within strata constructed from the ob-
served covariates38. Under this framework, the individual potential outcomes are assumed
to be fixed (and possibly unknown) quantities, with treatment assignment being the only
source of variability35. Repeated treatment assignments within each stratum can therefore
be used for valid inference about the causal effect, because individuals within each stra-
tum have identical observed covariates. When there are multiple covariates, some of which
may be continuous, it may be impossible to construct such strata using unique values of
the covariates where there are both treated and untreated individuals within each stratum.
Propensity score (PS) methods39,37 accommodate this by summarizing the multiple (contin-
uous) covariates in terms of the conditional probability of treatment given observed baseline
covariates. Strata can then be constructed by matching on the PS43, where individuals with
different treatments but otherwise similar PS (and therefore observed characteristics) are
grouped together in the same stratum.
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A key advantage of randomization inference is that it does not require invoking any as-
sumptions of random sampling from some hypothetical (super)population and is therefore,
appealing in observed study populations with no (known) well-defined sampling procedure.
However, randomization inference can have little or no power when the number of covariates
used for confounding adjustment is so large that the resulting number of (unique) hypotheti-
cal treatment assignments available for inference is small. In particular, if there are less than
α−1 hypothetical treatment assignments for an α-level test of the null hypothesis of no (in-
dividual) treatment effect, then the test will have no power to reject the null. Adjusting for
all available covariates, when only a subset are true confounders of the treatment-outcome
relation, may moreover lead to inefficient and unstable estimators of the treatment effect19,42.
For these stated reasons, confounder (or covariate) selection procedures are commonly em-
ployed, which seek to include only a minimally sufficient subset of covariates for confounding
adjustment. A small number of covariates is desirable to avoid potential biases due to mis-
specification of the outcome or PS model, or both, and to potentially increase statistical
power. Recently, Heinze et al24 and Witte and Didelez52 compared the ability of differ-
ent existing covariate selection methods to determine such a (minimal) subset. Witte and
Didelez further proposed a classification scheme for the methods based on the type of target
adjustment set and selection mechanism.
When selecting covariates for inclusion in the PS model, the conventional ‘design of ob-
servational studies’ typically suggests that only the treatment and covariates be used without
access to the outcome; see e.g., Rubin40, Stuart43 and Chapter 13 of Imbens and Rubin27.
However, a limitation of such approaches is that the predictive ability and significance of
covariates in the PS model are not directly informative about the extent to which confound-
ing bias is reduced47, and ultimately, the quality of the treatment effect estimator. Methods
that test only the covariate-treatment associations can easily delete important confounders,
yet worsen variance inflation by selecting non-confounding but strong predictors of treat-
ment49. Moreover, adjustment for covariates that are unrelated to the treatment but related
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to the outcome decreases the variance of the treatment effect estimator without increasing its
asymptotic bias9. Shortreed and Ertefaie41 propose an outcome-adaptive LASSO that seeks
to penalize covariates that predict treatment only, toward selecting covariates that are either
confounders of the treatment-outcome relation or (strongly) associated with the outcome
only, for inclusion in the PS model. A different approach is to directly evaluate the impact
of covariate selection on the treatment effect estimator by adopting a ‘change-in-estimate’
(CIE) perspective33,34. For example, a sequence of nested covariate subsets (ranging from
the empty set with no covariates to the full set containing all covariates) is constructed, and
the effect estimates that adjust for the covariates in each subset calculated. The (smallest)
covariate subset whose effect estimate remains unchanged (within some pre-specified thresh-
old, e.g., 10% of the absolute magnitude) after controlling for additional covariates is then
selected for inference on the treatment effect. Greenland et al21 improve on such a procedure
to optimize the quality of the effect estimator by considering changes in the approximate
mean-squared error (MSE) of the (conditional) effect estimator based on an outcome re-
gression model that includes treatment and the covariates in each subset. Vansteelandt
et al49, following Claeskens et al12 and Crainiceanu et al14, propose a ‘focused confounder
selection’ strategy that minimizes the MSE of the marginal effect estimator, using either
cross-validation or an asymptotic approximation, over the space of all possible covariate
subsets without relying on any particular sequence of nested subsets. Along similar lines,
collaborative targeted minimum loss-based estimation46 considers associations between each
covariate with both treatment and outcome when selecting covariates that are necessary to
adjust for confounding without inflating the (asymptotic) variance of the targeted minimum
loss estimator of the treatment effect. By focusing on the efficiency of the effect estima-
tor, the above-mentioned confounder selection approaches lean toward excluding covariates
that are associated with the treatment only, and including covariates that are related to
the outcome. However, they offer no insight into how the sensitivity of the treatment effect
estimator to the selected covariate subset affects the validity of inference following such a
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data-driven confounder selection procedure.
In view of this shortcoming, in this article, we propose a confounder selection strategy
that entails first prioritizing covariates for confounding adjustment, then extending the CIE
approach to select the smallest subset of covariates that yields a stable effect estimate. In the
first part, the covariates are ordered by decreasing priority for confounding adjustment us-
ing a forward selection approach. The resulting sequence therefore indexes a series of nested
covariate subsets: the smallest non-empty subset contains the most important covariate (ac-
cording to a specified criterion to be defined), the next smallest (non-empty) subset contains
the two most important covariates, and so on, with the largest subset containing all the co-
variates. To facilitate partitioning the space of all possible covariate subsets and visualizing
the resulting nested covariate subsets, we exploit the orbits framework of Crainiceanu et al14.
Orbits may be more generally used to select covariates for confounding adjustment, such as
via regression adjustment in the outcome model alone, or via inclusion in the outcome and
treatment models when calculating doubly-robust (marginal) treatment effect estimators.
However, in this article, we will focus on covariate selection for the PS model to be used
for matching in constructing strata for randomization inference. Each candidate covariate
is evaluated, in turn, following double selection4 principles, where the (partial) associations
between the outcome and the covariates, and between the exposure and the covariates, are
considered. Using double selection can increase the likelihood of selecting true confounders,
and account for the variability induced by carrying out covariate selection on the same data.
Explicitly ordering the covariates permits researchers to use substantive knowledge to refine
further which covariates should have higher or lower priorities for confounding adjustment
(in the PS model). Furthermore, no covariate is precluded from confounding adjustment
when estimating the treatment effect in the later part of the procedure because no p-value
threshold is imposed. Existing matching methods such as Zubizarreta55, among others, al-
ready allow users to incorporate substantive expertise in guiding the covariate adjustment
process. Keele and Small29 recently compared matching methods that allow for covariate
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prioritization with machine learning methods that require little user input toward obviating
biases due to observed confounding.
In the second part, the stability of the effect estimator across the series of nested covariate
subsets indexed by the prioritized covariates is assessed. In particular, common covariate
selection strategies predominantly identify a (minimally) sufficient subset of covariates for
confounding adjustment by optimizing a stopping criterion through separate evaluations of
each subset. In most realistic settings, it is impossible to determine whether the single
selected subset that met the stopping criterion is sufficient to eliminate all biases due to
observed (baseline) confounding. However, suppose that the available set of covariates con-
tains a (minimal) subset that is sufficient to adjust for confounding. The effect estimate that
adjusts for the covariates in this ‘sufficient’ subset should not systematically change when
other covariates not in this subset, e.g., those associated with either exposure or outcome,
but not both, are further adjusted for. Most covariate selection strategies account for such
relative insensitivity only to the extent of recommending in practice that a given proce-
dure be repeated for different subsets as a form of sensitivity analysis. In contrast, in this
article, we propose a selection strategy that works along a different principle than routine
methods, by exploiting this knowledge to explicitly assess the trajectory of the treatment
effect estimator across different (nested) covariate subsets. Given a series of nested covariate
subsets indexed by the prioritized covariates, the smallest subset that yields an unaltered
estimator (as more covariates are added) relative to the ‘benchmark’ estimate that adjusts
for all covariates is selected. Randomization inference about the causal effect can then be
carried out, using strata constructed by matching on the PS model containing the selected
covariates. While valid inference cannot be guaranteed following a data-driven selection of
covariates, we argue that nearly valid inference using the strategy proposed in this article
may be possible with the combined use of (i) double selection for prioritizing the covariates,
(ii) stability-based assessment to select covariates for confounding adjustment, and (iii) ran-
domization inference using PS matching to control the type I error when testing the null
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hypothesis of no (individual) treatment effect.
The rest of the article is as follows. In Section 2, the proposed two-part confounder se-
lection strategy is presented. A brief review of randomization inference is provided. In Sec-
tion 3, the ability of the proposed procedure to correctly select confounders of the treatment-
outcome relation, and to control the type I error rate when testing the null of no individual
treatment effect following covariate selection, is evaluated empirically in simulation studies.
The performance of the proposal is compared with existing methods for covariate selection,
and for inference on the treatment effect following covariate selection. In Section 4, the pro-
posed procedure is demonstrated using three different publicly available datasets commonly
used for causal inference. We conclude with a brief discussion in Section 5.
2 Confounder selection procedure
In this section we describe the proposed confounder selection procedure which proceeds in
two parts. In the first part, the covariates are ordered to reflect their (decreasing) priority
for confounding adjustment. In the second part, the smallest covariate subset that yields
a stable treatment effect estimator, even as more confounders are adjusted for, is then
selected. Following Vansteelandt et al49, we partition the space of all possible covariate
subsets into orbits14, where the j-th orbit comprises all subsets with j+1 covariates, including
an intercept. Let J denote the total number of observed covariates so that there are J + 1
different orbits. In this article, we assume that there are sufficient observations so that
the regression model for the treatment (outcome) containing all J observed covariates (and
treatment) can be fitted to the observed data.
2.1 Prioritizing covariates for confounding adjustment
The first part proceeds by repeating the following steps for each orbit indexed by j = 1, . . . , J .
1. Let Lj−1 denote the subset of covariates selected from the (j−1)-th orbit. When j = 1,
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let L0 denote the set containing the constant (intercept) 1 only. Denote each of the
remaining covariates that is not in the subset Lj−1 by Lj−1,k, k = 1, . . . , J − (j − 1).
These J − (j − 1) covariates are therefore candidates for selection in the j-th orbit.
2. For k = 1, . . . , J−(j−1), evaluate the (conditional) association between each candidate
covariate Lj−1,k and the treatment A by fitting the regression model for the treatment:
g{E(A|Lj−1, Lj−1,k)} = αj−1Lj−1 + αj−1,kLj−1,k, (1)
where αj−1 is a coefficient vector of length j (including the intercept), and g is a link
function such as the logit link, logit(x) = log{x/(1− x)}. Similarly, fit the regression
model for the outcome Y :
h{E(Y |A,Lj−1, Lj−1,k)} = ψj,kA+ βj−1Lj−1 + βj−1,kLj−1,k, (2)
where βj−1 is a coefficient vector of length j (including the intercept), and h is a link
function such as the identity link, h(x) = x. Non-continuous treatments, or outcomes,
can thus be accommodated using non-linear models with non-identity links g(·), or h(·),
respectively. The subscripts in the treatment coefficient ψj,k denote the dependence on
the covariates being adjusted for in the j-th orbit, (Lj−1, Lj−1,k). The regression models
for the treatment and outcome can therefore be used to compare the relative strengths
of the covariate-treatment and covariate-outcome (partial) associations, encoded by
αj−1,k and βj−1,k respectively, across all candidate covariates Lj−1,k, k = 1, . . . , J− (j−
1) that remained unselected in the subset Lj−1 from the (j − 1)-th orbit.
3. Test the hypotheses H0(A,L
j−1,k) : αj−1,k = 0 and H0(Y, Lj−1,k) : βj−1,k = 0 sepa-
rately using e.g., the Wald test. Denote the resulting p-values by pv(A,Lj−1,k) and
pv(Y, Lj−1,k) respectively. Let k∗ denote the index of the candidate covariate that
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minimizes the minimum of the p-values pv(A,Lj−1,k) and pv(Y, Lj−1,k); i.e.,
k∗ = arg min
k
{
min
(
pv(A,Lj−1,k), pv(Y, Lj−1,k)
)}
. (3)
Define the selected subset for the j-th orbit to be Lj = Lj−1 ∪ Lj−1,k∗ . Denote the
estimated (conditional) average treatment effect, given the selected covariates Lj in
the fitted outcome regression model, by ψ̂j = ψ̂j,k∗ .
Repeating the steps above for j = 1, . . . , J , therefore returns a sequence of covariates,
L0,k
∗
, . . . , LJ−1,k
∗
, that are ordered by their decreasing priority for confounding adjust-
ment. In particular, the ordered covariates induce a series of nested covariate subsets,
L1 ⊃ . . . ⊃ LJ .
Explicitly prioritizing the covariates for confounding adjustment enables further refine-
ment by leveraging established substantive knowledge. For example, covariates that are
known common causes of the treatment-outcome relation may be promoted to higher pri-
orities for adjustment by the researcher, whereas known instrumental variables (or “instru-
ments”) that only affect the treatment may be relegated to lower priorities. In general, de-
termining a variable to be an instrument requires (scientific) knowledge that the purported
instrument causes the treatment, but is entirely unassociated with the outcome except possi-
bly via treatment. Such considerable knowledge may be used to justify stringent assumptions
for instrumental variable analyses in certain contexts, but is rarely available in most substan-
tive analyses. Covariates that are a priori known to be correlated may be grouped together
(e.g., by ordering them consecutively in practice); however, adjusting for one confounder
that is correlated with another can (partially) eliminate the biases that may arise when the
latter is unadjusted for43. Taking the minimum of the p-values for the covariate-treatment
and covariate-outcome associations in (3) is inspired by double selection principles that take
advantage of information on both these associations. Assessing the association between each
candidate confounder with only the outcome (or treatment), instead of simultaneously as in
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(3), may potentially increase the chances of detecting variables that more strongly predict
outcome (or treatment). However, the associations between the covariates with either treat-
ment or outcome is then entirely ignored, which can potentially discard confounders that are
common causes of both treatment and outcome, but more strongly associated with one than
the other. Using double selection principles therefore reduces the risk of biased inference
from failing to adjust for confounders, while possibly producing more variable estimators,
but which arguably better reflects the inherent uncertainty in the data. Notwithstanding
the different orderings that may potentially result from different measures for prioritizing
the covariates, no covariates are precluded from confounding adjustment following this first
part of the procedure, because no pre-determined (significance-based) threshold is imposed
to eliminate covariates based solely on the absence of association.
In principle, the series of nested covariate subsets may be constructed using a backward or
stepwise selection approach; e.g., starting with the full model, the candidate covariate most
weakly associated with either treatment or outcome (e.g., the coefficient with the largest
p-value across the treatment and outcome regression models) can be iteratively discarded
from the selected subset in each orbit. However, a forward selection approach has the benefit
of avoiding convergence issues that may potentially arise when fitting regression models with
many covariates. When the number of covariates further exceeds the number of observations,
(unpenalized) regression models for the treatment and the outcome can theoretically be
fitted in orbits with fewer covariates than observations. Extensions to settings with high-
dimensional observed covariates, which require either limiting the largest orbit to a selected
covariate subset with fewer covariates than observations, or introducing penalized regression
models in larger orbits, are beyond the scope of this article and deferred to future work.
2.2 Stability of the effect estimator
In the second part of the proposed strategy, the smallest subset of covariates is selected for
confounding adjustment by assessing the stability of the treatment effect estimator across the
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nested covariate subsets. When there exists a (minimal) subset of covariates that is sufficient
to control for confounding, further adjusting for other covariates that are associated with
either exposure or outcome, but not both, should not systematically change the treatment
effect estimator. We therefore exploit this knowledge by explicitly evaluating the trajectory of
the treatment effect estimator across the (nested) covariate subsets induced by the prioritized
covariates in the first part.
We briefly introduce the notation before presenting the effect estimator for evaluating
stability. In a sample of size n, for individual i = 1, . . . , n, denote the binary treatment
by Ai and the outcome of interest by Yi. Let Y
a
i denote the potential outcome for Yi if,
possibly counter to fact, individual i had been assigned to treatment level Ai = a. In this
article, our interest is in the marginal treatment effect, defined as ψ = n−1
∑
i Y
1
i − Y 0i .
We propose comparing the treatment effect estimator from each orbit, ψ̂j, j = 1, . . . , J − 1,
with the ‘benchmark’ estimator ψ̂J that adjusts for all available covariates (i.e., from the
largest orbit). The choice of ψ̂J as a reference is motivated by its (asymptotic) unbiasedness
assuming that there are no unobserved confounders, so that the difference ψ̂j − ψ̂J can be
viewed as an approximate bias of ψ̂j relative to the true value of ψ. In this article, we will
use the standardized difference between the treatment effect estimators to evaluate their
stability across the different orbits, which takes the form:
ψˇj =
ψ̂j − ψ̂J√
V
(
ψ̂j − ψ̂J
) , j = 1, . . . , J − 1; (4)
where V(X) denotes the asymptotic variance of X. Our goal now is not to merely select the
orbit that minimizes the absolute value of (4), but to select the smallest orbit that yields
the most ‘stable’ value of (4). For example, the values of (4) may be plotted for each orbit,
as we will illustrate using the applied examples later, and the (smallest) orbit that yields a
value that does not ‘fluctuate’ as the orbits grow can be selected through visual inspection.
Alternatively, a diagnostic that numerically assesses the relative stability or (in)sensitivity
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of (4), while taking into account its variability, can directly optimize the quality of the
treatment effect estimator. In this article, we will use an inverse variance weighted average
of the differences ψ̂j − ψ̂J within a (moving) window of consecutive orbits. For simplicity,
we will use (symmetric) windows of width five centered around each orbit j = 3, . . . , J − 2.
The diagnostic for the j-th orbit is therefore defined as:
Qj =
j+2∑
k=j−2
wk{(ψ̂k − ψ̂J)− ψ̂j}2, (5)
where the weights wk and weighted average ψ̂j are respectively defined as:
wk =
{
V
(
ψ̂k − ψ̂J
)}−1
, ψ̂j =
(
j+2∑
k=j−2
wk
)−1 j+2∑
k=j−2
wk(ψ̂k − ψ̂J).
It is hence assumed that wJ = 0. Notwithstanding the ψ̂J estimators canceling each other
out within the quadratic term in (5), we use weights that are inversely proportional to the
variance of the approximate biases encoded by the differences ψ̂j − ψ̂J toward attaining un-
biased inference, rather than the variance of ψ̂j alone which focuses on the efficiency of the
effect estimator. Correlations between (non-)consecutive orbits are accounted for through
the dependence on the common benchmark estimator ψ̂J . The differences between the treat-
ment effect estimator ψ̂j from orbit j and the benchmark estimator ψ̂J , and the associated
variances, can be consistently estimated under settings with (non-)linear parametric regres-
sion models for the treatment and the outcome as described later. The smallest orbit with
the most stable value of (4) therefore minimizes the Q statistic; i.e.,
min
j=2,...,J−1
Qj. (6)
The weighted average as defined in (5) adopts the same form as ‘Cochran’s Q statistic’25 from
the meta-analysis literature for assessing heterogeneity of effect-size estimates from separate
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studies. Because the Q statistic is used merely to summarize the (in)stability of the effect
estimators across different orbits, and not compared against its asymptotic distribution for
inference, no assumption of independence between (non-)consecutive orbits is needed.
In general, the conditional effect estimator encoded by the treatment coefficient in the
(possibly non-linear) outcome model (2) may be inconsistent for the marginal treatment ef-
fect ψ due to non-collapsibility20. For example, when the outcome Y is binary and h(·) is set
as the logit link, the (transformed) coefficient exp(ψj,k) encodes an odds ratio for the outcome
that is not directly comparable with the marginal effect ψ. Hence even when all the (true)
confounders have been adjusted for, further adjustment for covariates that are associated
with outcome (only) can change the estimated odds ratio, and potentially result in an arti-
ficial lack of perceived stability. To facilitate assessing stability across different orbits when
evaluating non-collapsible effect measures, we recommend using an effect estimator based on
doubly robust standardization48. This approach delivers an unbiased estimator if either the
outcome or the treatment model is correctly specified, without amplifying biases that may
arise due to the misspecified model. Furthermore, this approach employs standardization
using traditional outcome regression, thereby inheriting the benefit of increased precision but
not the risks of biases due to extrapolation. Lastly, the (asymptotic) variance estimator in
(4) can be derived in closed form for computational efficiency. The estimator is calculated as
follows. For a binary treatment, denote the (non-linear) treatment model in (1), conditional
on the selected covariates in the j-th orbit Lj, by E(Ai|Lji ) = Pr(Ai = 1|Lji ) = expit(αjLji ),
where the subscript i of Lji denotes individual i and expit(x) = exp(x)/{1 + exp(x)}. Define
the inverse probability of treatment weight37 for individual i as:
W ji =
Ai
Pr
(
Ai = 1|Li = Lji
) + 1− Ai
1− Pr (Ai = 1|Li = Lji) . (7)
The weight W ji is the reciprocal of the conditional probability of individual i being assigned
the observed treatment Ai given the covariates L
j
i . Let Ŵ
j
i denote the estimated weights
13
obtained by substituting the maximum likelihood estimators (MLE) for αj in the treatment
model. Fit the outcome regression model E(Y |A,Lj) = h−1(ψ∗jA + βjLj) to the observed
data using the aforementioned weights. (The ∗ superscript indicates a conditional effect that
may differ from the marginal effect ψj.) Let Ê(Y |A,Lj) denote the fitted outcome model
obtained by plugging in the MLE for ψ∗j and βj. A doubly robust estimator of the average
potential outcome E(Y a) = n−1
∑
i Y
a
i for a = 0, 1, is then:
Ê(Y a) = n−1
∑
i
I{Ai = a}Ŵ ji
{
Yi − Ê(Y |A = Ai, Lji )
}
+ Ê(Y |A = a, Lji ), (8)
where I{B} = 1 if B is true and 0 otherwise. The estimator for the marginal treatment
effect ψ = E(Y 1)− E(Y 0) in the j-th orbit is therefore:
ψ̂j = n
−1∑
i
(2Ai− 1)Ŵ ji
{
Yi − Ê(Y |A = Ai, Lji )
}
+ Ê(Y |A = 1, Lji )− Ê(Y |A = 0, Lji ). (9)
When both treatment and outcome models are correctly specified, an asymptotic expansion
around ψ yields the so-called “influence function” for individual i as:
φji = (2Ai − 1)W ji
{
Yi − E(Y |A = Ai, Lji )
}
+ E(Y |A = 1, Lji )− E(Y |A = 0, Lji )− ψ. (10)
Let φ̂ji = (2Ai − 1)Ŵ ji
{
Yi − Ê(Y |A = Ai, Lji )
}
+ Ê(Y |A = 1, Lji ) − Ê(Y |A = 0, Lji ) − ψ̂j
denote the estimated influence function, obtained by plugging in the maximum likelihood
estimators for the coefficients in the treatment and outcome models, and substituting the
population expectation with a sample average. The variance of the difference between effect
estimators from two different orbits, e.g., j and k, is consistently estimated by the sample
variance (denoted by V̂) of the corresponding difference in estimated influence functions:
V̂
{
n1/2
(
ψ̂j − ψ̂k
)}
= (n− 1)−1
∑
i
(
φ̂ji − φ̂ki
)2
. (11)
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Consistency and asymptotic normality of the standardized difference (4) with mean zero and
variance one directly follow from the law of large numbers and the central limit theorem.
When both the treatment and outcome are continuous, and linear models for both may
be reasonably assumed, the (doubly robust) ordinary least squares effect estimator, and its
(asymptotic) variance estimator, are described in Appendix A.
2.3 Randomization inference by full matching on the propensity
score
In summary, the proposed confounder selection strategy proceeds in the following two parts.
A. Order the covariates, e.g., based on the strength of their (conditional) associations with
treatment and with outcome within each orbit, in decreasing priority for confounding
adjustment.
B. For the series of nested covariate subsets induced by the ordered covariates, calculate
the treatment effect estimator for each orbit. Select the covariate subset corresponding
to the smallest orbit that yields the most stable effect estimator.
Following selection of the confounders, randomization inference for the causal effect can
be readily carried out, using established methods for matching on the PS model given the
selected covariates. When there are multiple, possibly continuous, covariates, it may be im-
possible to stratify the sample using only the unique values of the covariates, while ensuring
that there is at least one treated and one untreated individual in each stratum. One possible
approach is subclassification on the Mahalanobis distance6,7, where linear combinations of
the covariates are partitioned into subclasses, but requires users to a priori define the number
of subclasses and the limits of each subclass. Another approach is Coarsened Exact Match-
ing26, where each covariate is temporarily coarsened for the purposes of exactly matching
individuals with the same values (of the coarsened covariates), but may require pruning
from the observed data any constructed strata with only treated or untreated individuals.
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In contrast, full matching using a specified propensity score model Pr(Ai = 1|Li) for a given
set of covariates Li creates a collection of matched groups, where each matched group is
guaranteed to contain at least one treated individual and at least one untreated individual.
Each matched group can therefore be viewed as a single stratum18. Full matching is opti-
mal in terms of minimizing the average of the covariate distances (and across all covariates)
between treated and untreated individuals within each matched group, and is particularly
effective at reducing bias due to observed confounding variables2,3. For these stated reasons,
we will employ full matching following the covariate selection procedure to construct strata
for randomization inference.
We will assume that conditioning on the strata constructed (using the propensity scores)
with the given covariates is sufficient for conditional exchangeability to hold; i.e., that each
individual’s probability of being assigned to treatment within each stratum does not depend
on the potential outcomes or any other variables, observed or otherwise. Under the causal
null of no individual treatment effect, defined as:
H0 : Y
1
i = Y
0
i , i = 1, . . . , n, (12)
the observed outcomes should be similarly distributed between treated and untreated indi-
viduals within each stratum. Let A = (A1, . . . , An) denote the treatment vector of length
n, and let a = (a1, . . . , an) denote a possible value for A. The plausibility of H0 can be
therefore be assessed by calculating the frequency of obtaining a test statistic that is at
least as ‘extreme’ (from H0) as its observed value assuming H0, over hypothetical assign-
ments of A holding the number assigned to treatment within each stratum fixed. Denote
the resulting set of hypothetical treatment assignments by Ω, where each assignment oc-
curs with equal probability |Ω|−1 under conditional exchangeability. Let Xi ∈ {1, . . . , R}
denote the stratum membership of individual i when the observed sample is partitioned into
R strata. We adopt the (weighted) sum of the stratum-specific total outcomes for treated
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individuals as the test statistic; i.e., τˆ(A) = n−1
∑
r nr
∑
i I{Xi = r}AiYi, where nr is the
total number of individuals in stratum r. A (two-sided) p-value may then be defined as
pv(Ω)= |Ω|−1∑
a∈Ω
I {|τˆ(a)|≥|τˆ(A)|}, where τˆ(a) is the test statistic obtained by replacing Ai
in τˆ(A) with ai under treatment a, and larger (absolute) values of τˆ(A) suggest stronger
evidence against H0. When it is not computationally feasible to enumerate Ω exactly - as is
often in most realistic settings - an approximation based on e.g., C = 1000 random draws of
a from Ω may be used instead.
3 Simulation studies
Simulation studies were conducted under different data-generating scenarios to empirically
evaluate the ability of the proposal to (i) correctly select confounders, and (ii) yield hypoth-
esis tests that preserved the type I error rate after data-driven covariate selection. Let p
denote the number of candidate observed baseline covariates. We partitioned the covariates
into four subsets as follows. Confounders in the first subset simultaneously affected treat-
ment and outcome; their indices were denoted by S1 = {1, 2}. Covariates in the second
subset affected outcome only; their indices were denoted by S2 = {3, 4}. Instruments in the
third subset were associated with treatment only; their indices were denoted by S3 = {5, 6}.
Covariates in the fourth subset were unassociated with either treatment or outcome; their
indices were denoted by S4 = {7, . . . , p}. The subsets were used exclusively to generate the
observed data and not to inform any applied method.
We describe the study for one scenario and defer details of other scenarios. Datasets with
sample size n = 80 and p = 25 candidate covariates were generated under the null of no
individual treatment effect, i.e., H0 : Y
1
i = Y
0
i , i = 1, . . . , n, as follows. Let Lis denote the s-
th observed baseline covariate for individual i. For s = 1, . . . , p, each covariate was randomly
(and independently) draw from a standard normal distribution; i.e., Lis ∼ N (0, 1). Denote
the resulting vector of p covariates by Li = (Li1, . . . , Lip). The (true) propensity score for
17
each individual was determined as Pr(Ai = 1|Li) = expit (
∑p
s=1 γsLis), where γs = 1.0 if
s ∈ S1 (a confounder), or γs = 1.6 if s ∈ S3 (an instrument), or 0 otherwise. The observed
treatment was then randomly drawn as Ai ∼ Bernoulli{Pr(Ai = 1|Li)}. The underlying
outcome was determined as Y ∗i =
∑p
s=1 βsLis, where βs = 0.8 if s ∈ S1 ∪ S2 (a confounder
or an outcome-only predictor), or 0 otherwise. The observed outcome was then randomly
drawn as Yi ∼ N (Y ∗i , 42).
We compared the ability of the proposal to correctly select the true confounders with the
following variable selection methods that were implemented in publicly available software
packages on the Comprehensive R Archive Network. We briefly describe each method and
refer readers to the respective references for further details.
S0. The stability-based confounder selection procedure proposed in this article (‘Stability’).
S1. The Augmented Backward Elimination (‘ABE’) algorithm17 that combines backward
variable selection with a change-in-estimate criterion. A significance-based threshold
for a (standardized) regression coefficient of interest is used to determine the final
model. Because the method carries out variable selection for a single regression model,
we used the outcome model where treatment was a ‘passive’ variable that was always in
the final model. The algorithm is implemented in the abe function5 (https://CRAN.
R-project.org/package=abe). We set all options to their default levels.
S2. The feature selection algorithm using random forests8,53 as implemented in the Boruta
function31 (https://CRAN.R-project.org/package=Boruta). The method starts with
the full model and iteratively compares the relative ‘importance’ of observed variables
with those of randomly generated non-informative variables, where the latter are cre-
ated by permuting the former. Observed variables that have significantly worst impor-
tance than randomly generated ones are consecutively dropped. Observed variables
that have significantly better importance are decided as ‘Confirmed.’ Because the
method carries out variable selection for a single regression model, we used the out-
18
come model (starting with the full model conditional on treatment and all candidate
covariates). Covariates that were decided as ‘Confirmed’ were selected.
S3. The covariate selection approach using the model-free backward elimination algorithms
of De Luna et al15 for nonparametric estimation of the marginal treatment effect. Co-
variates were selected based on whether there was significant evidence that they were
in at least one of the minimal subsets Q0 and Q1 that rendered treatment conditionally
independent of the potential outcomes Y 0 (in the control group) and Y 1 (in the treat-
ment group) respectively15. The algorithms are implemented in the cov.sel function
from the CovSel package23 (https://CRAN.R-project.org/package=CovSel). Be-
cause all the candidate covariates were continuous, we used marginal co-ordinate hy-
pothesis tests (type = "dr"). Due to the small sample size, only algorithm 1 could
be used22; we set all other options to their default levels, including the pre-determined
significance level of 0.1.
S4. The Consistent Significance Controlled Variable Selection algorithms54 that select
only significant variables in a linear regression model. Because different algorithms
are available in the SignifReg function30 (https://CRAN.R-project.org/package=
SignifReg), we describe the algorithm corresponding to the default levels of the op-
tions. Forward selection starting with the intercept-only outcome model (because
treatment could not be forced into the starting model) was used. At each step, the
variable that generated a new model having the smallest maximum p-value among the
Wald tests for the regression coefficients was added to the current model. This step
was repeated so long as every regression coefficient was significant after correcting for
multiple testing using the false discovery rate.
The average probabilities of including the (true) confounders among the selected covari-
ates, with the average number of covariates selected, for each method are plotted in Figure 1.
The Boruta and SignifReg methods selected the smallest number of covariates on average
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but failed to select any confounders about half the time. The ABE and CovSel methods se-
lected at least one confounder almost as frequently as the proposed stability-based method,
although ABE selected exactly both confounders only about half the time.
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Figure 1: Scatterplot of the average empirical probabilities of selecting the true confounders
(vertical axis) against the average number of selected covariates (horizontal axis), for each
covariate selection method. The left and right panels respectively depict the proportions of
simulated datasets where at least one confounder was included, and exactly both confounders
were included, among the selected covariates. Each horizontal bar represents the interquartile
range of the number of selected covariates.
We then assessed the ability of the selected covariates using each method to adjust for
observed confounding, by including only (main effects for) the selected covariates in a PS
model for full matching. The resulting empirical distribution of the (randomization) p-values
for testing H0 (as described in Section 2.3) following the use of each data-driven covariate
selection method was calculated. In addition, we considered the following methods for testing
H0:
M1. Full matching using the ‘target’ PS model with only the true confounders (Lis, s ∈ S1)
and the outcome-only predictors (Lis, s ∈ S2).
M2. Randomization inference without adjusting for any covariates (‘Empty PS model’).
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M3. A Wald test using the sandwich-based standard errors for the treatment effect in a
simple linear regression of outcome on treatment, with weights being the reciprocal of
the fitted probabilities of the observed treatments from the outcome-adaptive LASSO
procedure41 (‘OAL’).
M4. A Wald test using the (post-)double selection4 method for inference on (low-dimensional)
target coefficients in a high-dimensional linear model. Penalized (linear) regression
models for the outcome, and the treatment, on the observed covariates are first fitted,
then the treatment effect is estimated by regressing the outcome on the treatment and
all covariates with non-zero coefficient estimates in the fitted models. This method
(‘HDM’) is implemented in the rlassoEffect function of the hdm package11.
M5. A Wald test using discrete collaborative targeted minimum loss-based estimation (CTMLE)
with greedy forward search46. A (nested) sequence of candidate (parametric) PS mod-
els is constructed using a forward selection algorithm, by starting with the intercept-
only model then adding (the main effect for) one additional covariate at each step.
The targeted minimum loss estimator of the treatment effect corresponding to each
PS model in the sequence is calculated. Cross-validation is then used to select the PS
model that minimizes a specified loss function for the estimator (e.g., its MSE using
the sum of squared residuals). This procedure (‘CTMLE: discrete’) is implemented
in the ctmleDiscrete function of the ctmle package10. We implemented all options
as recommended in the online package vignette (https://cran.r-project.org/web/
packages/ctmle/vignettes/vignette.html).
M6. A Wald test using CTMLE with LASSO by fitting a penalized logistic regression model
to estimate the PS model28. Instead of a forward selection approach, the sequence of
candidate PS models is now indexed by different values of the LASSO regularization
penalty. As in the discrete CTMLE approach above, the PS model that minimizes
the (cross-validated) loss function of the treatment effect estimator is chosen. This
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procedure is implemented in the ctmleGlmnet function of the ctmle package.
Methods M1 and M2 did not require any covariate selection because the covariates in the PS
model were either correctly specified (M1), or ignored (M2). The empirical distributions of
the p-values for testing H0 using these methods are plotted in the left panel of Figure 2. As
expected, failing to adjust for any covariates (M2) induced unobserved confounding of the
treatment-outcome relation that resulted in inflated type I error rates; this is shown by the
curve above the diagonal. Randomization inference with full matching using the target PS
model (M1) approximately controlled the type I error rate at its nominal level empirically;
this is shown by the curve being close to the diagonal.
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Figure 2: Empirical distributions of p-values for testing H0. The covariates in the PS model
for full matching were either known (left panel), or selected using one of the plotted methods.
The random variable X on the vertical axis denotes the p-value. The diagonal is plotted as
a solid (gray) line with reduced opacity.
The empirical distributions of the randomization p-values, following the use of the ABE,
CovSel, and Stability covariate selection methods to determine the PS model for full match-
ing, are plotted in the right panel of Figure 2. Because all three methods had similarly
high probabilities of selecting (at least one of) the two true confounders, they approximately
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controlled the type I error empirically at all significance levels. In contrast, the Boruta
and SignifReg methods resulted in inflated type I error rates as shown in the left panel of
Figure 3. Furthermore, none of the methods using (approximate) p-values from Wald tests
of H0 preserved the type I error rates empirically, as shown in the right panel of Figure 3.
The CTMLE methods also resulted in much smaller p-values than the HDM method on
average. To understand why, we compared the estimates of the average treatment effect and
its standard error using these two approaches in Table 1. The standard error estimates using
CTMLE were (much) smaller than those using HDM on average, possibly due in part to
the ‘super-efficiency’ properties of CTMLE which is aimed at optimizing the bias-variance
tradeoff. However, the effect (point) estimates using CTMLE were more biased (and more
variable) than those using HDM, resulting in larger empirical MSE (sum of the squared
point estimate, and the variance estimate) on average. Hence the CTMLE effect estimates
were seemingly more efficient whereby the Wald tests were rejected more frequently. For
completeness, two Bayesian methods for treatment effect estimation following covariate se-
lection were also considered: the Bayesian Adjustment for Confounding (BAC) algorithm
as implemented in the bac function in the bacr package50, and the Bayesian causal effect
estimation algorithm44 as implemented in the ABCEE function in the BCEE package45. Only
the latter preserved the type I error rate empirically, but this is not guaranteed in general.
Details on their implementation, and the results, are provided in Appendix B.
Method Mean effect estimate E.s.e Mean s.e. estimate A.s.e Mean MSE
HDM 0.59 1.29 1.20 0.18 1.76
CTMLE: discrete 1.14 3.81 1.06 4.50 3.19
CTMLE: LASSO 1.10 2.78 0.68 0.22 2.46
Table 1: Empirical summaries of estimates of the treatment effect and its standard error
(s.e.) using the CTMLE and HDM methods. The true value of the treatment effect was
zero. The empirical s.e. (E.s.e.) of the effect estimates, and asymptotic s.e. (A.s.e.) of the
standard error estimates (i.e., its standard deviation across the simulated datasets), were
considered. The average (square root of) the empirical MSE of the effect estimators were
presented. All results were rounded to two decimal places.
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Figure 3: Empirical distributions of p-values for testing H0. In the left panel, different
covariate selection methods were used to determine the PS (model) for full matching. In the
right panel, inference for the treatment effect was carried out using either OAL, HDM, or
one of the two versions of CTMLE. The random variable X on the vertical axes denote the
p-value. The diagonal is plotted as a solid (gray) line with reduced opacity.
3.1 Other settings
The simulation study was extended to different settings with either (i) a binary outcome,
where the observed outcome was randomly drawn as Yi ∼ Bernoulli{expit(Y ∗i )}, or (ii)
more covariates, e.g., p = 60, or (iii) twice as many number of instruments, by setting
S3 = (5, . . . , 8) and S4 = (9, . . . , p). In addition, we considered a different scenario by
introducing certain covariates that induced “collider bias36” when adjusted for. The data-
generating mechanism was modified as follows, with all parameters adopting the same val-
ues as before unless otherwise stated. Randomly draw two unobserved variables Uiv ∼
N (0, 1/16), v = 1, 2. For the observed covariates indexed by s ∈ S3, randomly draw
Lis ∼ N (2Ui1 + 2Ui2, 1/2), so that these covariates had (approximately) mean zero and
unit variance. All other (observed) covariates were randomly drawn from the standard nor-
mal distribution as before. The (true) propensity score for each individual was determined
as Pr(Ai = 1|Li) = expit (
∑p
s=1 γsLis + νUi1), where γs = 0, s ∈ S3, and ν = 2. The un-
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derlying outcome was determined as Y ∗i = β0 +
∑p
s=1 βsLis + νUi2. Hence the covariates
Lis indexed by s ∈ S3 were no longer instruments, but were now separately associated with
treatment Ai, and outcome Yi, through the unobserved common causes Ui1, and Ui2, respec-
tively. Because these covariates were colliders along the path linking treatment and control,
i.e., A ← U1 → Ls ← U2 → Y , controlling for these covariates would result in biased effect
estimates.
We summarize the findings here, and present the detailed results for each of the sixteen
different data-generating scenarios in Appendix B. The proposed Stability method selected
(exactly both) confounders more than 70% of the time empirically for almost all settings,
with the lowest probability of about 50% when there were four instruments. Furthermore,
when there were no instruments (and only covariates that may induce collider bias when
adjusted for), the probability was more than 85%. For almost all settings, the number of
selected covariates was approximately half the total number of candidate covariates p, but
when there were p = 60 covariates and the outcome was continuous, the number of selected
covariates was only about p/4 on average. The Stability method therefore preserved the type
I error rate empirically under almost all settings, except when there were p = 60 covariates
and the outcome was binary, due in part to overfitting in the logistic outcome model.
The ABE method was less likely to select (exactly both) confounders than the Stability
method when the outcome was continuous and there were only p = 25 covariates. When
the outcome was binary, or there were p = 60 covariates, or both, the ABE method tended
to select almost all the available covariates on average, thus selecting the true confounders
(much) more frequently than the Stability method. For these reasons, the ABE method
seemingly preserved the type I error rate empirically under certain settings. The CovSel
method selected the confounders at a similar empirical probability as the Stability method
when there were p = 25 covariates, but at a much lower probability when there were p = 60
covariates, which resulted in inflated type I error rates. The Boruta and SignifReg methods
managed to select (exactly both) confounders at best less than half of the time under certain
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settings, although the SignifReg method was seemingly able to preserve the type I error
rate empirically under most settings but which may not hold in more general settings. The
CTMLE and HDM methods were considered only in settings with p = 25 covariates, where
their empirical type I error rates were inflated.
In conclusion, we demonstrated empirically that the proposed stability-based strategy
either correctly included (both) confounders more frequently, or selected a smaller subset of
covariates, or both, than the other covariate selection methods under comparison. Further-
more, using full matching on the selected covariates empirically preserved the type I error
rate approximately following data-driven covariate selection.
4 Illustration with applied examples
The proposed confounder selection strategy was illustrated using three publicly available
datasets. For comparison, the covariates selected using each of ABE, Boruta, CovSel1, and
SignifReg methods were also determined. Following each data-driven covariate selection
method, full matching on the PS model containing only (main effects for) the selected co-
variates was used to construct strata. Randomization p-values for testing the null of no
(individual) treatment effect were obtained using C = 2000 assignments. Because the ‘tar-
get’ PS models were unknown in practice, the results using a (full) PS model containing all
the available covariates were presented for comparison. In addition, the (marginal) treatment
effect estimator (9), and its asymptotic variance estimator, given the selected covariates were
calculated. However, we emphasize that (asymptotic) inference for the (standardized) treat-
ment effect by merely using critical values from a standard normal distribution is unlikely to
be valid, even after correctly selecting the covariates that adjust for all confounding, because
1To allow for both continuous and non-continuous covariates in these data, kernel-based smoothing (type
= "np") with algorithm 2 was used for the CovSel model-free backward elimination method. Covariates were
selected if there was significant evidence, at the (default) significance level of 0.1, that they were in at least
one of the minimal subsets Z0 and Z1 that rendered treatment conditionally independent of the potential
outcomes Y 0 (in the control group) and Y 1 (in the treatment group) respectively15. All other options were
set at their default values.
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the variance estimator does not reflect the uncertainty induced by carrying out covariate
selection on the same data.
4.1 AIDS Clinical Trials Group Study 175
The ‘ACTG175’ dataset was from an AIDS randomized clinical trial, and was distributed
as part of the speff2trial package via the Comprehensive R Archive Network (https:
//CRAN.R-project.org/package=speff2trial). The trial compared monotherapy using
either zidovudine or didanosine alone with combination therapy using either zidovudine and
didanosine, or zidovudine and zalcitabine, in adults infected with the human immunodefi-
ciency virus type I whose CD4 T cell counts were between 200 and 500 per cubic millimeter.
Treatment was (re)coded as A = 0 for therapy using either zidovudine or didanosine only,
and A = 1 for therapies combining zidovudine and either didanosine or zalcitabine. A binary
outcome was defined based on whether a participant’s CD4 T cell count at 96 ± 5 weeks
was greater than 250 or not. The full dataset contained 2139 participants with 17 candidate
(baseline) covariates, but we only considered a reduced dataset with 1342 participants hav-
ing complete data so that a PS model with all covariates could be fitted. In addition, one
covariate (prior zidovudine use) that was singular in the reduced dataset was dropped.
The standardized differences (4) for each orbit (versus the largest orbit) are plotted in
Figure 4. The differences, which may be viewed as approximate biases for the estimators in
each orbit, tended to fluctuate around zero for smaller orbits, before stabilizing (just above
zero) in the larger orbits. Because this was a randomized controlled trial, confounding of
the treatment-outcome relation was unlikely, but could have been induced by the exclusion
of incomplete observations. Adjusting for different covariates therefore did not greatly affect
the treatment effect estimates, as shown by the relatively small magnitudes of the differ-
ences (less than one standard deviation from zero). The ordered covariates are displayed
in Table 2. Because of the relatively few covariates, we considered windows of width three
when calculating the Cochran’s Q statistic in (5) to evaluate stability. Although treatment
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was randomly assigned, the orbit that was deemed to be most stable contained 15 (out of 16
observed) covariates. The results given the selected covariates using each of the methods, as
well as without any covariates (‘Empty’), are included in Table 2. Across all of the covariate
selection methods, the estimated effect was about 0.10, with the randomization p-value for
testing H0 much smaller than a significance level of e.g., 0.01, thus suggesting strong evidence
that combination therapy had an effect on CD4 T cell count.
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Figure 4: Standardized difference (‘Std. diff.;’ (4)), between the treatment effect estimator
from each orbit and from the largest orbit, for the ACTG175 data. The solid black curve
is a local cubic polynomial smoother. The most stable orbit minimizing Cochran’s Q (6) is
indicated by a filled triangle.
4.2 LaLonde labor training program
The ‘LaLonde’ dataset was from a labor training program32 used to demonstrate causal
effect estimation adjusting for confounding; see e.g., Dehejia and Wahba16 and Abadie and
Imbens1. We considered the version of the dataset that was distributed as part of the
CovSel package23. There were 297 units assigned to participate in a national supported
work demonstration (A = 1), and 314 control units (A = 0) drawn from survey datasets.
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Covariates Stable ABE Boruta CovSel SignifReg Empty All
CD4 T cell count at baseline (cd40) TRUE TRUE TRUE TRUE
antiretroviral history (str2) TRUE TRUE TRUE TRUE TRUE
CD8 T cell count at baseline (cd80) TRUE TRUE TRUE TRUE
Karnofsky score (karnof) TRUE TRUE TRUE TRUE TRUE
weight in kg at baseline (wtkg) TRUE TRUE TRUE
history of intravenous drug use (drugs) TRUE TRUE TRUE TRUE
age TRUE TRUE TRUE
symptomatic indicator (symptom) TRUE TRUE TRUE TRUE
history of antiretroviral therapy (preanti) TRUE TRUE
homosexual activity (homo) TRUE TRUE TRUE
gender TRUE TRUE TRUE TRUE TRUE
race TRUE TRUE TRUE
hemophilia (hemo) TRUE TRUE
prior non-zidovudine therapy (oprior) TRUE TRUE TRUE
zidovudine use in last 30 days (z30) TRUE TRUE TRUE
stratified antiretroviral history (strat) TRUE TRUE
p-value for testing H0 < 1×10−3 2.5×10−3 5×10−3 3×10−3 < 1×10−3 < 1×10−3 < 1×10−3
Treatment effect estimate 0.104 0.106 0.104 0.090 0.103 0.096 0.104
Standard error 0.022 0.022 0.025 0.025 0.022 0.026 0.022
Table 2: Comparison of the selected confounders (‘TRUE’) in the ACTG175 data using
different methods. The covariates were ordered following double selection principles (3).
The p-values for testing H0, and estimated average (marginal) treatment effect and standard
error (up to three decimal places), are stated in the last three rows. The results using a PS
model with either no covariates (‘Empty’), or all the available covariates (‘All’) are shown
in the two rightmost columns.
The (continuous) outcome Y was the level of post-intervention earnings in 1978. There were
10 candidate (baseline) covariates, with four continuous variables (age; years of schooling;
and historical earnings in 1974 and 1975), and six binary variables (ethnicity being African-
American, or Hispanic, or neither; martial status; high school diploma; and indicators of
whether historical earnings in 1974 and 1975 were zero).
The standardized differences (4) for each orbit (versus the largest orbit) are plotted in
Figure 5. There were no sudden changes in the differences between consecutive orbits, which
tended to zero in the larger orbits. The ordered covariates are displayed in Table 3. Because
of the relatively few covariates, we considered windows of width three when calculating the
Cochran’s Q statistic in (5) to evaluate stability. The most stable orbit contained 9 (out of
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10 observed) covariates. The results given the selected covariates using each of the methods
were included for comparison in Table 3. The randomization-based p-value for testing H0
using the proposed stability(-based) strategy was far above reasonable significance levels,
and in line with the results following the other methods, therefore suggesting little evidence
that the work demonstration affected later earnings.
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Figure 5: Standardized difference (‘Std. diff.;’ (4)), between the treatment effect estimator
from each orbit and from the largest orbit, for the LaLonde data. The solid black curve
is a local cubic polynomial smoother. The broken line indicates the 97.5% quantile of the
standard normal distribution. The most stable orbit minimizing Cochran’s Q (6) is indicated
by a filled triangle.
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Covariates Stable ABE Boruta CovSel SignifReg All
African-American ethnicity TRUE TRUE TRUE TRUE
real earnings in 1974 TRUE TRUE TRUE TRUE TRUE
zero earnings in 1974 TRUE TRUE TRUE TRUE TRUE TRUE
years of schooling TRUE TRUE TRUE TRUE TRUE
real earnings in 1975 TRUE TRUE TRUE TRUE TRUE
martial status TRUE TRUE TRUE TRUE
Hispanic ethnicity TRUE TRUE TRUE
high school diploma TRUE TRUE TRUE TRUE
zero earnings in 1975 TRUE TRUE TRUE TRUE
age TRUE TRUE TRUE
p-value for testing H0 0.630 0.689 0.935 0.535 0.644 0.657
Treatment effect estimate -182 -114 -669 154 -900 -182
Standard error 881 776 715 766 675 886
Table 3: Comparison of the selected confounders (‘TRUE’) in the LaLonde data using dif-
ferent methods. The covariates were ordered following double selection principles (3). The
p-values for testing H0 (up to three decimal places), and estimated average (marginal) treat-
ment effect and standard error (nearest integer), are stated in the last three rows. The
results using a PS model with all the available covariates are shown in the rightmost column
(‘All’).
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4.3 Right Heart Catheterization
The ‘RHC’ dataset was from an observational study on the effectiveness of Right Heart
Catheterization (RHC) in the initial care of critically ill patients13, and was distributed
as part of the Hmisc package via the Comprehensive R Archive Network (https://CRAN.
R-project.org/package=Hmisc). The data contained information on hospitalized adult
patients at five medical centers in the U.S. who participated in the Study to Understand
Prognoses and Preferences for Outcomes and Risks of Treatments (SUPPORT). The treat-
ment variable was defined to be whether or not a patient received an RHC within 24 hours
of admission. A binary outcome was defined based on whether a patient died at any time
up to 180 days since admission. The full dataset contained 5735 participants with 73 covari-
ates. However, to fit the PS model with all available covariates, we considered a reduced
dataset with 2707 participants having complete data on 72 covariates (one covariate that
was singular in the reduced dataset was dropped).
The standardized differences (4) for each orbit (versus the largest orbit) are plotted in
Figure 6. It can be seen that the trajectory of the differences oscillated across consecutive
orbits, and was relatively stable in different regions where the smoother could be considered
to be relatively flat. Visually inspecting the fluctuations led us to consider windows of
width seven when calculating the Cochran’s Q statistic in (5) to evaluate stability. The
orbit deemed to be most stable contained 29 (out of 72 observed) covariates. The values
of Cochran’s Q plotted in Figure 7 indicated that a larger orbit (with 69 covariates) was
similarly stable, with a (locally minimal) value close to the (globally) minimal value attained
by a smaller orbit (with 29 covariates). When wider windows of width nine were used to
evaluate stability, the selected orbit contained 28 covariates (one fewer than with windows of
width seven). For comparison, 34, 20 and 13 covariates were selected using the ABE, Boruta,
and SignifReg methods respectively. Due to space constraints, the ordered covariates, as well
as those selected using each method, are displayed in Table 6 in the Appendix. The CovSel
method was omitted as it could not be completed successfully.
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Adjusting for the selected covariates using the proposed stability(-based) strategy yielded
an estimated (marginal) treatment effect of 0.06, with a 95% Wald confidence interval of
(0.016, 0.103) that excluded zero and suggested that RHC significantly affected mortality
within 180 days. These results were similar to the findings using the matching and machine
learning methods under comparison in Table 1 of Keele and Small29. However, full matching
using a PS model with (only main effects for) the selected covariates yielded 664 strata, with
half containing just two individuals within each stratum. The thin strata limited the num-
ber of (unique) hypothetical treatment assignments, which resulted in a more conservative
randomization p-value of 0.193 for testing H0.
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Figure 6: Standardized difference (‘Std. diff.;’ (4)), between the treatment effect estimator
from each orbit and from the largest orbit, for the RHC data. The solid black curve is a
local cubic polynomial smoother. The broken line indicates the 2.5% quantile of the standard
normal distribution. The most stable orbit minimizing Cochran’s Q (6) is indicated by a
filled triangle.
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Figure 7: Values of Cochran’s Q (5) for each orbit j for the RHC data. The minimal value
is indicated by a filled triangle.
5 Discussion
In this article, we have proposed a confounder selection strategy that explicitly assesses
the stability of the treatment effect estimator across different (nested) covariate subsets as
a selection criterion. The proposal was demonstrated empirically to yield approximately
valid inference following a data-driven selection of covariates through the combined use of
(i) double selection for prioritizing the covariates, (ii) stability-based assessment to select
covariates for confounding adjustment, and (iii) randomization inference using full matching
to control the type I error when testing the null of no (individual) treatment effect.
There are several avenues of possible future research related to the confounder selection
strategy that focuses on the stability of the treatment effect estimator developed in this
article. When ordering the orbits in the first part, any covariate selection method that
permits prioritizing the covariates for confounder selection can conceptually be incorporated
into the proposed stability-based strategy. For example, using double selection principles
may reduce the chances of selecting predictors of outcome (only), because adjusting for such
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covariates will only improve the variance but not the bias of the treatment effect estimator in
large samples. To overcome this potential loss in efficiency, a different method that prioritizes
such covariates that can curtail variance inflation, such as the outcome-adaptive LASSO, may
be considered for ordering the covariates instead. For example, the covariates (standardized
to have mean zero and variance one) may be ordered based on the absolute magnitude
of their estimated (standardized) coefficients in the penalized PS model. Notwithstanding
such possible improvements, we elected not to use this approach as it would unlikely deliver
approximately valid inference as compared to double selection. Other approaches using the
Bayesian framework may also be considered. For example, Wilson and Reich51 propose
a decision-theoretic approach to covariate selection via penalized credible regions of the
regression parameters that form sets of (nested) candidate models. The solution paths
based on the posterior probabilities of each covariate being selected may then be used to
order the covariates. Similarly, Bayesian variable selection methods, e.g., Talbot et al44,
and Bayesian model averaging methods, e.g., Wang et al50, may also be used to order the
covariates based on their decreasing posterior probabilities of inclusion in the PS model.
Because different covariate selection methods employ different selection mechanisms that
target different adjustment sets, comparing the abilities of different approaches to prioritize
the covariates in delivering valid inference is an area of future work.
Evaluating different methods or criteria for judging stability in the second part of the
proposed procedure is another direction for future research. One possibility is to impose
either pre-defined or data-adaptive thresholds on the values of the chosen statistic to limit
the candidate orbits for consideration. For example, in the illustration using the RHC data,
the most stable orbit (see Figure 6) was determined to be (just) inside the 95% quantiles of the
(asymptotically standard normally-distributed) standardized differences. One may consider
evaluating stability only among orbits with standardized differences that are closer to zero,
e.g., within one standard deviation. The Q statistic as proposed in (5) considered windows
of width five, so that if the approximate bias ψ̂k − ψ̂J is constant for k = j − 2, · · · , j + 2,
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then even if each value of ψ̂k is far from ψ̂J , the Q statistic will flag orbit j as having a stable
(but biased) effect estimator. Other possibilities for judging stability include considering
windows of different widths following visual inspection of the trajectory, as we carried out
in the applied examples, or alternative criteria that measure stability differently, or directly
optimizing the trajectory of the effect estimator. Finally, we have focused on testing the
null of no (individual) treatment effect. In general, given a set of (selected) covariates in the
PS model, randomization-based confidence intervals can be constructed by inverting a series
of hypothesis tests under maintained hypotheses of assumed constant non-zero individual
treatment effects. However, such an approach merely conditions on the (selected) covariates,
and does not account for the data-driven covariate selection procedure. Valid post-selection
(randomization) inference using e.g., modified bootstrap approaches17, are therefore an area
of future work.
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A Effect estimator assuming linear treatment and out-
come models
In this section, we consider settings where linear treatment and outcome models can be
reasonably assumed, by setting g(·) and h(·) as the identity link in (1) and (2) respectively.
Under linear models for both treatment and outcome in the j-th orbit, respectively E(A|Lj) =
αjL
j and E(Y |A,Lj) = ψjA + βjLj, the ordinary least squares (OLS) estimator of the
treatment effect ψ̂j in the j-th orbit obeys the following asymptotic expansion around ψ:
n1/2
(
ψ̂j − ψ
)
= n−1/2
∑
i
(
Ai − αjLji
) (
Yi − ψjAi − βjLji
)
E {A(A− αjLj)} + op(1). (13)
The estimator is unbiased so long as either the treatment or outcome model is correctly
specified. It follows from the above expansion that the influence function for individual i is:
φji =
(
Ai − αjLji
) (
Yi − ψjAi − βjLji
)
E {A(A− αjLj)} .
Let φ̂ji =
(
Ai − α̂jLji
) (
Yi − ψ̂jAi − β̂jLji
)/
n−1
∑
iAi
(
Ai − α̂jLji
)
denote the estimated in-
fluence function, obtained by plugging in the OLS estimators α̂j, ψ̂j, β̂j for the coefficients
in the treatment and outcome models, and substituting the population expectation with a
sample average. The variance of the difference between effect estimators from two different
orbits, e.g., j and k, is consistently estimated by the sample variance of the corresponding
difference in estimated influence functions:
V̂
{
n1/2
(
ψ̂j − ψ̂k
)}
= (n− 1)−1
∑
i
(
φ̂ji − φ̂ki
)2
. (14)
It follows that under settings with linear regression models for the treatment and the out-
come, consistency and asymptotic normality of the standardized difference (4) with mean
zero and variance one directly follow from the law of large numbers and the central limit
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theorem.
B Simulation study results
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Prob. confounders selected No. selected covariates Type I error rate (α = 0.05)
S3 p |S3| Y (A) (B) (C) (SR) (St) (A) (B) (C) (SR) (St) (No) (A) (B) (C) (SR) (St) (Ta)
IV 25 2 Con. 0.46 0.07 0.69 0.06 0.75 9.37 1.79 6.51 1.83 9.93 0.13 0.06 0.10 0.07 0.07 0.06 0.06
IV 25 2 Bin. 0.95 0.32 0.60 0.43 0.81 19.30 3.15 3.75 3.22 10.94 0.27 0.11 0.14 0.07 0.09 0.08 0.05
IV 25 4 Con. 0.49 0.07 0.58 0.10 0.50 9.49 1.84 7.74 1.97 9.28 0.10 0.05 0.08 0.04 0.05 0.06 0.04
IV 25 4 Bin. 0.95 0.31 0.48 0.44 0.69 19.46 3.07 4.12 3.20 11.17 0.19 0.11 0.10 0.08 0.06 0.09 0.05
IV 60 2 Con. 0.52 0.04 0.02 0.08 0.67 36.95 2.36 0.40 2.78 16.26 0.12 0.10 0.09 0.12 0.08 0.08 0.05
IV 60 2 Bin. 0.98 0.23 0.28 0.37 0.91 58.20 3.48 10.45 4.03 33.98 0.24 0.23 0.13 0.21 0.07 0.21 0.05
IV 60 4 Con. 0.54 0.04 0.02 0.07 0.46 36.51 2.35 0.44 2.80 16.33 0.10 0.09 0.08 0.10 0.05 0.06 0.05
IV 60 4 Bin. 0.97 0.23 0.23 0.40 0.84 58.42 3.48 10.05 4.03 33.85 0.20 0.17 0.12 0.16 0.06 0.16 0.04
Co. 25 2 Con. 0.49 0.06 0.82 0.07 0.95 9.21 1.75 5.32 1.86 10.70 0.19 0.08 0.14 0.07 0.10 0.06 0.06
Co. 25 2 Bin. 0.95 0.28 0.72 0.37 0.96 18.43 3.07 3.41 3.11 10.50 0.45 0.07 0.20 0.09 0.12 0.05 0.05
Co. 25 4 Con. 0.46 0.06 0.80 0.07 0.95 9.18 1.80 5.30 1.81 10.55 0.19 0.06 0.15 0.07 0.10 0.06 0.06
Co. 25 4 Bin. 0.94 0.30 0.70 0.38 0.97 18.58 3.13 3.43 3.13 10.71 0.47 0.07 0.19 0.09 0.12 0.05 0.06
Co. 60 2 Con. 0.52 0.04 0.04 0.06 0.85 36.54 2.40 0.68 2.72 13.38 0.18 0.12 0.12 0.17 0.09 0.08 0.05
Co. 60 2 Bin. 0.96 0.22 0.36 0.32 0.95 58.04 3.50 10.66 3.86 31.37 0.41 0.37 0.20 0.28 0.11 0.28 0.04
Co. 60 4 Con. 0.53 0.03 0.05 0.06 0.86 36.58 2.28 0.77 2.75 13.31 0.17 0.12 0.14 0.16 0.10 0.07 0.05
Co. 60 4 Bin. 0.97 0.22 0.34 0.33 0.95 58.07 3.45 10.36 3.85 31.52 0.44 0.40 0.20 0.29 0.12 0.28 0.05
Table 4: Results for each covariate selection method used to determine the PS model for full matching. The methods were
no covariates (‘No’), ABE (A) , Boruta (B), CovSel (C), SignifReg (SR), Stability (St), or the known target covariates (Ta).
The empirical proportions (‘Prob.’) of simulated datasets where exactly both confounders were included among the selected
covariates, the average number (‘No.’) of selected covariates, and the type I error rate of the randomization tests (significance
level α = 0.05) were calculated. The observed covariates indexed by s ∈ S3 either affected treatment only (‘IV’), or induced
collider bias when adjusted for (‘Co’). There were p observed covariates. The outcome Y was either continuous (‘Con.’) or
binary (‘Bin.’). All results were rounded to two decimal places.
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Type I Mean effect est. E.s.e Mean s.e. est. A.s.e
S3 p |S3| Y (i) (ii) (iii) (i) (ii) (iii) (i) (ii) (iii) (i) (ii) (iii) (i) (ii) (iii)
IV 25 2 Con. 0.60 0.43 0.11 1.07 0.98 0.64 2.71 3.77 1.28 0.68 0.82 1.21 0.20 0.30 0.19
IV 25 2 Bin. 0.66 0.60 0.12 0.17 0.11 0.07 0.26 0.30 0.14 0.07 0.10 0.13 0.02 0.36 0.02
IV 25 4 Con. 0.59 0.48 0.08 1.02 0.84 0.60 2.58 4.40 1.23 0.60 0.86 1.23 0.14 2.72 0.21
IV 25 4 Bin. 0.65 0.62 0.09 0.14 0.08 0.07 0.24 0.32 0.14 0.07 0.10 0.13 0.05 0.39 0.02
Co. 25 2 Con. 0.41 0.35 0.08 0.36 0.61 0.32 2.38 2.24 1.13 0.92 0.91 1.07 0.30 0.67 0.14
Co. 25 2 Bin. 0.35 0.46 0.08 0.07 0.06 0.03 0.24 0.22 0.13 0.10 0.11 0.12 0.03 0.44 0.01
Co. 25 4 Con. 0.40 0.36 0.08 0.30 0.38 0.33 2.43 2.02 1.10 0.92 0.91 1.06 0.27 0.50 0.14
Co. 25 4 Bin. 0.34 0.46 0.09 0.07 0.07 0.05 0.24 0.22 0.12 0.10 0.10 0.12 0.03 0.05 0.01
Table 5: Empirical type I error rate (α = 0.05) of the p-values for testing H0, estimates (est.) of the treatment effect, and its
standard error (s.e.), using the CTMLE and HDM methods. The methods were (i) CTMLE: LASSO, (ii) CTMLE: discrete,
or (iii) HDM. The empirical s.e. (E.s.e.) of the effect estimates, and asymptotic s.e. (A.s.e.) of the standard error estimates
(i.e., its standard deviation across the simulated datasets), were considered. The observed covariates indexed by s ∈ S3 either
affected treatment only (‘IV’), or induced collider bias when adjusted for (‘Co’). There were p observed covariates. The outcome
Y was either continuous (‘Con.’) or binary (‘Bin.’). The true value of the treatment effect was zero. All results were rounded
to two decimal places.
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Two Bayesian methods for treatment effect estimation with covariate selection were also
employed. For the Bayesian Adjustment for Confounding (BAC) algorithm, as implemented
in the bac function in the bacr package50, the number of MCMC iterations was set to
5000, with a burn-in of 500, and a thinning parameter of 10. For the Bayesian causal effect
estimation algorithm44, as implemented in the ABCEE function in the BCEE package45, default
levels of all options were used. The argument omega was set to the recommended value of
500
√
n. For each method, the posterior probability that the estimated treatment effect was
greater than zero was used as a p-value for testing H0. The results for two selected settings
are plotted in Figure 8 below.
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Figure 8: Empirical distributions of p-values for testing H0 using Bayesian approaches for
causal effect estimation. Observed covariates indexed by s ∈ S3 = {5, 6} either affected
treatment only (left panel), or induced collider bias when adjusted for (right panel). There
were p = 25 covariates, and the outcome was continuous. The random variable X on the
vertical axes denote the p-value. The diagonal is plotted as a solid (gray) line with reduced
opacity.
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C Selected covariates in the RHC data
Covariates Stable ABE Boruta SignifReg All
Cancer: Metastatic (ca meta) TRUE TRUE TRUE TRUE TRUE
Support model estimate of the prob. of
surviving 2 months (surv2md1)
TRUE TRUE TRUE TRUE
Heart rate (hrt1) TRUE TRUE TRUE TRUE
Secondary disease: Colon Cancer
(cat2 colon)
TRUE TRUE TRUE
Orthopedic Diagnosis (ortho) TRUE TRUE TRUE TRUE TRUE
Temperature (temp1) TRUE TRUE
Mean blood pressure (meanbp1) TRUE TRUE
Duke Activity Status Index (das2d3pc) TRUE TRUE TRUE TRUE
Cardiovascular Diagnosis (card) TRUE TRUE TRUE
Primary disease: MOSF with Sepsis
(cat1 mosfsep)
TRUE TRUE TRUE
Primary disease: CHF (cat1 chf) TRUE TRUE TRUE
PaO2/FIO2 ratio (pafi1) TRUE TRUE
Albumin (alb1) TRUE TRUE TRUE TRUE TRUE
Secondary disease category: MOSF with
Sepsis (cat2 mosfsep)
TRUE TRUE
Immunosupperssion, Organ Transplant,
HIV Positivity, Diabetes Mellitus With-
out End Organ Damage, Diabetes Melli-
tus With End Organ Damage, Connective
Tissue Disease (immunhx)
TRUE TRUE
Hematocrit (hema1) TRUE TRUE TRUE
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Covariates Stable ABE Boruta SignifReg All
Primary disease category: Cirrhosis
(cat1 cirr)
TRUE TRUE
Weight (wtkilo1) TRUE TRUE TRUE TRUE TRUE
Upper GI Bleeding (gibledhx) TRUE TRUE
Urine output (urin1) TRUE TRUE TRUE TRUE TRUE
Sepsis Diagnosis (seps) TRUE TRUE
Glasgow Coma Score (scoma1) TRUE TRUE TRUE TRUE
Definite Myocardial Infarction (amihx) TRUE TRUE TRUE TRUE
Sodium (sod1) TRUE TRUE TRUE
PaCo2 (paco21) TRUE TRUE
Medical insurance: Medicaid (ins caid) TRUE TRUE TRUE
Respiratory Rate (resp1) TRUE TRUE TRUE TRUE TRUE
Respiratory Diagnosis (resp) TRUE TRUE
White Blood Cell Count (wblc1) TRUE TRUE
Creatinine (crea1) TRUE TRUE TRUE
Primary disease category: Coma
(cat1 coma)
TRUE TRUE
(age) TRUE TRUE TRUE
Primary disease category: MOSF with
Malignancy (cat1 mosfmal)
TRUE TRUE TRUE
Secondary disease category: MOSF with
Malignancy (cat2 mosfmal)
TRUE TRUE TRUE
Secondary disease category: Coma
(cat2 coma)
TRUE TRUE
Secondary disease category: Cirrhosis
(cat2 cirr)
TRUE TRUE
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Covariates Stable ABE Boruta SignifReg All
(sex) TRUE TRUE
Solid Tumor, Metastatic Disease, Chronic
Leukemia/Myeloma, Acute Leukemia,
Lymphoma (malighx)
TRUE TRUE TRUE
Income: 11-25k (income2) TRUE TRUE
Acute MI, Peripheral Vascular Disease,
Severe Cardiovascular Symptoms with
NYHA-Class III, Very Severe Cardiovascu-
lar Symptoms with NYHA-Class IV (car-
diohx)
TRUE TRUE
Dementia, Stroke or Cerebral Infact,
Parkinson’s Disease (dementhx)
TRUE
Arterial PH (ph1) TRUE TRUE
Metabolic Diagnosis (meta) TRUE TRUE
Cancer: Yes (ca yes) TRUE TRUE
Medical insurance: Medicare (ins care) TRUE TRUE
Gastrointestinal Diagnosis (gastr) TRUE TRUE
Primary disease category: COPD
(cat1 copd)
TRUE
Years of education (edu) TRUE
Congestive Heart Failure (chfhx) TRUE
Chronic Renal Disease, Chronic Hemodial-
ysis or Peritoneal Dialysis (renalhx)
TRUE TRUE
Income: Under 11k (income1) TRUE TRUE
APACHE score (aps1) TRUE
Neurological Diagnosis (neuro) TRUE TRUE
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Hematologic Diagnosis (hema) TRUE
Potassium (pot1) TRUE TRUE
Chronic Pulmonary Disease, Severe Pul-
monary Disease, Very Severe Pulmonary
Disease (chrpulhx)
TRUE
Bilirubin (bili1) TRUE TRUE
Trauma Diagnosis (trauma) TRUE TRUE
Psychiatric History, Active Psychosis or
Severe Depression (psychhx)
TRUE
Medical insurance: None (ins no) TRUE
Race: Other (raceother) TRUE
Primary disease category: Colon Cancer
(cat1 colon)
TRUE
Medical insurance: Medicare and Medicaid
(ins carecaid)
TRUE
Do Not Resuscitate (dnr1) TRUE TRUE
Transfer from Another Hospital (transhx) TRUE
Secondary disease category: Lung Cancer
(cat2 lung)
TRUE TRUE
Cirrhosis, Hepatic Failure (liverhx) TRUE TRUE
Medical insurance: Private (ins pcare) TRUE
Renal Diagnosis (renal) TRUE
Income: 25-50k (income3) TRUE TRUE
Race: African American (raceblack) TRUE
Primary disease category: Lung Cancer
(cat1 lung)
TRUE TRUE
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p-value for testing H0 0.193 0.051 0.596 0.061 0.377
Treatment effect estimate 0.059 0.059 0.006 0.046 0.072
Standard error 0.022 0.019 0.019 0.018 0.022
Table 6: Comparison of the selected confounders
(“TRUE”) in the RHC data using different methods. The
covariates were ordered following double selection prin-
ciples (3). The p-values for testing H0, and estimated
average (marginal) treatment effect and standard error,
are stated (up to three decimal places) in the last three
rows. There were no results for the CovSel covariate se-
lection method as it could not be implemented for this
dataset. The results using a PS model with all the avail-
able covariates are shown in the rightmost column (‘All’).
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